USPTO serial 98351159
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
ANDREW D. BOCHNER
ANDREW D. BOCHNER BOCHNER PLLC1040 AVENUE OF THE AMERICAS15TH FLOORNEW YORK, NY 10018| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable software using artificial intelligence and machine learning for performing and recording research, and for performing diagnostic tests in the fields of biology, pharmacology, bioengineering and life sciences; Downloadable software using artificial intelligence for performing and recording research, and for performing diagnostic tests in the fields of biology, pharmacology, bioengineering and life sciences specifically related to healthcare; Downloadable computer software and programs using artificial intelligence for data and software processing, data generation, and for understanding and analyzing that data; downloadable computer programs and downloadable computer software using artificial intelligence for developing, running and analyzing algorithms that are able to learn to analyze, classify, and take actions in response to exposure to data; downloadable computer software for use in simulation environments for the purpose of testing artificial intelligence agents, algorithms and programs; downloadable computer software and programs for diagnosing health conditions, prescribing treatments and writing prescriptions, designing clinical tests and forecasting clinical test results, searching for clinical trial participants, analysing medical images, analysing data, and developing pharmaceuticals and chemical compounds | ACTIVE | — |
| 042 | Software as a service (SAAS) services featuring software using artificial intelligence for performing and recording research, and for performing diagnostic tests in the fields of biology, pharmacology, bioengineering and life sciences; Research in the field of artificial intelligence technology; technology consulting in the field of artificial intelligence; Software as a service (SaaS) services featuring software for diagnosing health conditions, prescribing treatments and writing prescriptions, designing clinical tests and forecasting clinical test results, searching for clinical trial participants, analyzing medical images, analyzing data, and developing pharmaceuticals and chemical compounds; Scientific and technological services, namely, research in the fields of biotechnology, drug discovery and development, and diagnostic preparations; Advisory services relating to scientific research; Scientific research; Engineering services; Technical consultancy services relating to computer programming; Research and development services in the field of engineering; Development of computer programs; Software design and development | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 16, 2025 | MAB3 | ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL | — |
| Jul 16, 2025 | ABN3 | ABANDONMENT - AFTER EX PARTE APPEAL | — |
| Jul 16, 2025 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Jun 5, 2025 | EXFB | EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF | — |
| Feb 21, 2025 | GEA1 | NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED | — |
| Feb 21, 2025 | GECD | ACTION DENYING REQ FOR RECON E-MAILED | — |
| Feb 21, 2025 | CNCF | ACTION CONTINUING FINAL - COMPLETED | — |
| Feb 20, 2025 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Feb 20, 2025 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Feb 20, 2025 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Feb 19, 2025 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Nov 19, 2024 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Nov 19, 2024 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 19, 2024 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 7, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 6, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 6, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 6, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 6, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 6, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 6, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 30, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 10, 2024 | NWAP | NEW APPLICATION ENTERED | — |